These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35043687)

  • 1. Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.
    Leith A; Ribbands A; Kim J; Last M; Barlow S; Yang L; Ghate SR
    Future Oncol; 2022 Mar; 18(8):937-951. PubMed ID: 35043687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world genetic testing patterns in metastatic castration-resistant prostate cancer.
    Shore N; Ionescu-Ittu R; Yang L; Laliberté F; Mahendran M; Lejeune D; Yu L; Burgents J; Duh MS; Ghate SR
    Future Oncol; 2021 Aug; 17(22):2907-2921. PubMed ID: 33906368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations.
    Shore N; Oliver L; Shui I; Gayle A; Wong OY; Kim J; Payne S; Amin S; Ghate S
    J Urol; 2021 Apr; 205(4):977-986. PubMed ID: 33332152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches.
    Manneh R; Verson CA; Martin A; Delgado A; Isaacsson Velho PH; Manduley A; Tejado L; Rodríguez Y; Vargas C; Barata PC
    JCO Precis Oncol; 2024 May; 8():e2300628. PubMed ID: 38748947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
    Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
    Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer.
    Schostak M; Bradbury A; Briganti A; Gonzalez D; Gomella L; Mateo J; Penault-Llorca F; Stenzinger A; Wyatt AW; Bjartell A
    Eur Urol Oncol; 2024 Jun; 7(3):344-354. PubMed ID: 37714762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.
    Heiss BL; Chang E; Gao X; Truong T; Brave MH; Bloomquist E; Shah A; Hamed S; Kraft J; Chiu HJ; Ricks TK; Tilley A; Pierce WF; Tang L; Abukhdeir A; Kalavar S; Philip R; Tang S; Pazdur R; Amiri-Kordestani L; Kluetz PG; Suzman DL
    J Clin Oncol; 2024 May; 42(15):1851-1860. PubMed ID: 38452327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration-resistant prostate cancer in real-world clinical practice: The multi-institutional observational ZENSHIN study.
    Uemura H; Oya M; Kamoto T; Sugimoto M; Shinozaki K; Morita K; Koto R; Takahashi M; Nii M; Shin E; Nonomura N
    Cancer Med; 2023 Mar; 12(5):5265-5274. PubMed ID: 36358026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis.
    Dong B; Yang B; Chen W; Du X; Fan L; Yao X; Xue W
    Med Oncol; 2022 May; 39(5):96. PubMed ID: 35599270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.
    Isaacsson Velho P; Qazi F; Hassan S; Carducci MA; Denmeade SR; Markowski MC; Thorek DL; DeWeese TL; Song DY; Tran PT; Eisenberger MA; Antonarakis ES
    Eur Urol; 2019 Aug; 76(2):170-176. PubMed ID: 30293905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
    Antonarakis ES; Lu C; Luber B; Liang C; Wang H; Chen Y; Silberstein JL; Piana D; Lai Z; Chen Y; Isaacs WB; Luo J
    Eur Urol; 2018 Aug; 74(2):218-225. PubMed ID: 29439820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair Mutations.
    Bobbili PJ; Ivanova J; Solit DB; Mettu NB; McCall SJ; Dhawan M; DerSarkissian M; Arondekar B; Chang J; Niyazov A; Lee J; Huq R; Green M; Turski M; Lam P; Muthukumar A; Guo T; Mohan M; Zhang A; Duh MS; Oh WK
    Clin Genitourin Cancer; 2024 Jun; 22(3):102080. PubMed ID: 38653037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologous Recombination Repair Gene Mutations in Prostate Cancer: Prevalence and Clinical Value.
    Fan Y; Liu Z; Chen Y; He Z
    Adv Ther; 2024 Jun; 41(6):2196-2216. PubMed ID: 38767824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer.
    Lee AM; Saidian A; Shaya J; Nonato T; Cabal A; Randall JM; Millard F; Stewart T; Rose B; Tamayo P; McKay RR
    Clin Genitourin Cancer; 2022 Dec; 20(6):515-523. PubMed ID: 35871039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer.
    Barata PC; Assayag J; Li B; Siu G; Niyazov A
    JAMA Oncol; 2024 Jul; 10(7):975-977. PubMed ID: 38696212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer.
    Gonzalez D; Mateo J; Stenzinger A; Rojo F; Shiller M; Wyatt AW; Penault-Llorca F; Gomella LG; Eeles R; Bjartell A
    J Pathol Clin Res; 2021 Jul; 7(4):311-325. PubMed ID: 33630412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Gene Next-Generation Sequencing Panel for Analysis of
    Maloberti T; De Leo A; Coluccelli S; Sanza V; Gruppioni E; Altimari A; Zagnoni S; Giunchi F; Vasuri F; Fiorentino M; Mollica V; Ferrari S; Miccoli S; Visani M; Turchetti D; Massari F; Tallini G; de Biase D
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting defects in homologous recombination repair for metastatic, castration-resistant prostate cancer.
    Chau V; Madan RA; Figg WD
    Cancer Biol Ther; 2020 Oct; 21(10):884-887. PubMed ID: 32844710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Metastatic Castration-resistant Prostate Cancer: Are PARP Inhibitors Shifting the Paradigm?
    Fujimoto N; Harada K; Shiota M; Tomisaki I; Minato A; Nagata Y; Kimuro R; Harada M; Fujisawa M
    Anticancer Res; 2021 Oct; 41(10):4687-4695. PubMed ID: 34593416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.
    Annala M; Struss WJ; Warner EW; Beja K; Vandekerkhove G; Wong A; Khalaf D; Seppälä IL; So A; Lo G; Aggarwal R; Small EJ; Nykter M; Gleave ME; Chi KN; Wyatt AW
    Eur Urol; 2017 Jul; 72(1):34-42. PubMed ID: 28259476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.